SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial

Clinical trial NCT05222620 · RECRUITING

Trial details

NCT number: NCT05222620
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Malignant Neoplasm in the Brain Metastatic Malignant Solid Neoplasm

Start date: 2022-03-14
Primary completion: 2027-02-15
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.